Page 49 Volume 17 - N.3 - 2009

Dor (2009) 17
40. Coggeshall RE. Fos, nociception and the dorsal horn. Prog Neuro- 59. Sevcik MA, Ghilardi JR, Peters CM, et al. Anti-NGF therapy pro-
biol. 2005;77(5):299-352. foundly reduces bone cancer pain and the accompanying increase
41. Cruz CD, Ferreira D, McMahon SB, Cruz F. The activation of the ERK in markers of peripheral and central sensitization. Pain. 2005;115(1-
pathway contributes to the spinal c-fos expression observed after 2):128-41.
noxious bladder stimulation. Somatosens Moto Res. 2006;24(1- 60. Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F. The
2):15-20. function neutralizing anti-TrkA antibody MNAC13 reduces inflamma-
42. Harris JA. Using c-fos as a neural marker of pain. Brain Res Bull. tory and neuropathic pain. Proc Natl Acad Sci USA. 2007;104(8):
1998;45(1):1-8. 2985-90.
43. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord 61. Wild KD, Bian D, Zhu D, et al. Antibodies to nerve growth factor
neurons following sensory stimulation. Nature. 1987;328(6131):632-4. reverse established tactile allodynia in rodent models of neuro-
44. Lima D, Avelino A. Spinal c-fos expression is differentially induced pathic pain without tolerance. J Pharmacol Exp Ther. 2007;322(1):
by brief or persistent noxious stimulation. Neuroreport. 1994;5(15): 282-7.
1853-6. 62. Dmitrieva N, McMahon SB. Sensitization of visceral afferents by
45. Avelino A, Cruz F, Coimbra A. Intravesical resiniferotoxin desensi- nerve growth factor in the adult rat. Pain. 1996;66(1):87-97.
tizes rat bladder sensory fibres without causing intense noxious 63. Farquhar-Smith WP, Jaggar SI, Rice AS. Attenuation of nerve growth
excitation. A c-fos study. Eur J Pharmacol. 1999;378:17-22. factor-induced visceral hyperalgesia via cannabinoid CB(1) and
46. Charrua A, Cruz CD, Cruz F, Avelino A. Transient receptor potential CB(2)-like receptors. Pain. 2002;97(1-2):11-21.
vanilloid subfamily 1 is essential for the generation of noxious bladder 64. Dawbarn D, Fahey M, Watson J, et al. NGF receptor TrkAd5: thera-
input and bladder overactivity in cystitis. J Urol. 2007;177(4):1537-41. peutic agent and drug design target. Biochem Soc Trans. 2006;34(Pt
47. Cruz CD, Avelino A, McMahon SB, Cruz F. Increased spinal cord 4):587-90.
phosphorylation of extracellular signal-regulated kinases mediates 65. Watson JJ, Fahey MS, van den Worm E, et al. TrkAd5: A novel
micturition overactivity in rats with chronic bladder inflammation. Eur therapeutic agent for treatment of inflammatory pain and asthma. J
J Neurosci. 2005;21(3):773-81. Pharmacol Exp Ther. 2006;316(3):1122-9.
48. Lantéri-Minet M, Bon K, de Pommery J, Michiels JF, Menetrey D. 66. Djouhri L, Dawbarn D, Robertson A, Newton R, Lawson SN. Time
Cyclophosphamide cystitis as a model of visceral pain in rats: mod- course and nerve growth factor dependence of inflammation-induced
el elaboration and spinal structures involved as revealed by the alterations in electrophysiological membrane properties in nocicep-
expression of c-Fos and Krox-24 proteins. Exp Brain Res. 1995; tive primary afferent neurons. J Neurosci. 2001;21(22): 8722-33.
105(2):220-32. 67. Robertson AG, Banfield MJ, Allen SJ, et al. Identification and struc-
49. Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. ture of the nerve growth factor binding site on TrkA. Biochem Bio-
Semin Cell Dev Biol. 2006;17(5):592-604. phys Res Commum. 2001;282(1):131-41.
50. Slack SE, Pezet S, McMahon SB, Thompson SN, Malcangio M. 68. Hu VY, Zvara P, Dattilio A, et al. Decrease in Bladder Overactivity
Brain-derived neurotrophic factor induces NMDA receptor subunit with REN1820 in rats with cyclophosphamide induced cystitis. J
one phosphorylation via ERK and PKC in the rat spinal cord. Eur J Urol. 2005;173(3):1016-21.
Neurosci. 2004;20(7):1769-78. 69. Fjell J, Cummins TR, Dib-Hajj SD, Fried K, Black JA, Waxman SG.
51. Kim HS, Lee SJ, Kim DS, Cho HJ. Effects of brain-derived neu- Differential role of GDNF and NGF in the maintenance of two TTX-
rotrophic factor and neurotrophin-3 on expression of mRNAs encod- resistant sodium channels in adult DRG neurons. Brain Res Mol
ing c-Fos, neuropeptides and glutamic acid decarboxylase in cul- Brain Res. 1999;67(2):267-82.
tured spinal neurons. Neuroreport. 2000;11(17):3873-6. 70. Chudler EH, Anderson LC, Byers MR. Nerve growth factor depletion
52. Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and by autoimmunization produces thermal hypoalgesia in adult rats.
mechanical hyperalgesia in humans after intradermal injection of Brain Res. 1997;765(2):327-30.
capsaicin. Pain. 1989;38(1):99-107. 71. Fjell J, Cummins TR, Fried K, Black JA, Waxman SG. In vivo NGF
53. Gwak YS, Nam TS, Paik KS, Hulsebosch CE, Leem JW. Attenuation deprivation reduces SNS expression and TTX-R sodium currents in
of mechanical hyperalgesia following spinal cord injury by adminis- IB4-negative DRG neurons. J Neurophysiol. 1999;81(2):803-10.
tration of antibodies to nerve growth factor in the rat. Neurosci Lett. 72. Priest BT, Murphy BA, Lindia JA, et al. Contribution of the tetrado-
2003;336(2):117-20. toxin-resistant voltage-gated sodium channel Na v 1.9 to sensory
54. Jimenez-Andrade JM, Martin CD, Koewler NJ, et al. Nerve growth transmission and nociceptive bahevior. Proc Natl Acad Sci USA.
factor sequestering therapy attenuates non-malignant skeletal pain 2005;102(26):9382-7.
following fracture. Pain. 2007;133(1-3):183-96. 73. Kuo HC, Liu HT, Chancellor MB. Urinary nerve growth factor is a better
55. Koewler NJ, Freeman KT, Buus RJ, et al. Effects of a monoclonal biomarker than detrusor wall thickness for the assessment of overactive
antibody raised against nerve growth factor on skeletal pain and bladder with incontinence. Neurourol Urodyn. 2010;29(3):482-7.
bone healing after fracture of the C57BL/6J mouse femur. J Bone 74. Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor
Miner Res. 2007;22(11):1732-42. expression triggers bladder overactivity. J Pain. 2004;5(3):150-6.
56. Ro LS, Chen ST, Tang LM, Jacobs JM. Effect of NGF and anti-NGF 75. Yoshimura N, Bennett NE, Hayashi Y, et al. Bladder overactivity and
on neuropathic pain in rats following chronic constriction injury of hyperexcitability of bladder afferent neurons after intrathecal delivery
the sciatic nerve. Pain. 1999;79(2-3):265-74. of nerve growth factor in rats. J Neurosci. 2006;26(42):10847-55.
57. Sabsovich I, Wei T, Guo TZ, et al. Effect of anti-NGF antibodies in a 76. Zhang X, Huang J, McNaughton PA. NGF rapidly increases mem-
rat tibia fracture model of complex regional pain syndrome type I. brane expression of TRPV1 heat-gated ion channels. EMBO J.
Pain. 2008;138(1):47-60. 2005;24(24):4211-23.
58. Schwartz JP, Pearson J, Johnson EM. Effect of exposure to anti-NGF 77. McMahon SB, Bennett DL, Bevan S. Inflammatory mediators and
on sensory neurons of adult rats and guinea pigs. Brain Res. modulators. Em: McMahon SB, Koltzenburg M, eds. Textbook of
1982;244(2):378-81. Pain. Londre: Elsevier; 2006. p. 49-72.

DOR

48